1. Home
  2. ALLR vs MGIH Comparison

ALLR vs MGIH Comparison

Compare ALLR & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • MGIH
  • Stock Information
  • Founded
  • ALLR 2004
  • MGIH 1978
  • Country
  • ALLR United States
  • MGIH Hong Kong
  • Employees
  • ALLR N/A
  • MGIH N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • MGIH Publishing
  • Sector
  • ALLR Health Care
  • MGIH Consumer Discretionary
  • Exchange
  • ALLR Nasdaq
  • MGIH Nasdaq
  • Market Cap
  • ALLR 15.8M
  • MGIH 18.0M
  • IPO Year
  • ALLR N/A
  • MGIH 2023
  • Fundamental
  • Price
  • ALLR $1.01
  • MGIH $1.52
  • Analyst Decision
  • ALLR Strong Buy
  • MGIH
  • Analyst Count
  • ALLR 1
  • MGIH 0
  • Target Price
  • ALLR $9.00
  • MGIH N/A
  • AVG Volume (30 Days)
  • ALLR 536.3K
  • MGIH 19.9K
  • Earning Date
  • ALLR 08-08-2025
  • MGIH 08-12-2025
  • Dividend Yield
  • ALLR N/A
  • MGIH N/A
  • EPS Growth
  • ALLR N/A
  • MGIH N/A
  • EPS
  • ALLR N/A
  • MGIH N/A
  • Revenue
  • ALLR N/A
  • MGIH $28,866,993.00
  • Revenue This Year
  • ALLR N/A
  • MGIH N/A
  • Revenue Next Year
  • ALLR N/A
  • MGIH N/A
  • P/E Ratio
  • ALLR N/A
  • MGIH N/A
  • Revenue Growth
  • ALLR N/A
  • MGIH N/A
  • 52 Week Low
  • ALLR $0.61
  • MGIH $1.32
  • 52 Week High
  • ALLR $6.00
  • MGIH $6.83
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 49.17
  • MGIH 39.75
  • Support Level
  • ALLR $1.03
  • MGIH $1.61
  • Resistance Level
  • ALLR $1.17
  • MGIH $1.70
  • Average True Range (ATR)
  • ALLR 0.08
  • MGIH 0.06
  • MACD
  • ALLR -0.00
  • MGIH -0.01
  • Stochastic Oscillator
  • ALLR 28.89
  • MGIH 0.00

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.

Share on Social Networks: